Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Potential EEG Biomarkers and Antiepileptogenic Strategies for Epilepsy in TSC

NCT01767779 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.

NCT NCT01767779
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01767779 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Potential EEG Biomarkers and Antiepileptogenic Strategies for Epilepsy in TSC
Lead sponsor
University of Alabama at Birmingham
Phase
Observational
Overall status
Completed
Start date
September 30, 2012
Completion date
December 31, 2018
Enrollment
40 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

tuberous sclerosis complex